633 filings
Page 26 of 32
8-K
NBSE
NeuBase Therapeutics Inc
22 Apr 13
Ohr Pharmaceutical Announces $5 Million Financing from Exercise of Warrants
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
28 Mar 13
Unregistered Sales of Equity Securities
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
21 Mar 13
Ohr Pharmaceutical Announces Results from OHR/AVR118 Phase II Trial in Cancer Cachexia
12:00am
10-Q
2013 Q1
NBSE
NeuBase Therapeutics Inc
Quarterly report
19 Feb 13
12:00am
NT 10-Q
NBSE
NeuBase Therapeutics Inc
14 Feb 13
Notice of late quarterly filing
12:00am
10-K
2012 FY
NBSE
NeuBase Therapeutics Inc
Annual report
9 Jan 13
12:00am
NT 10-K
NBSE
NeuBase Therapeutics Inc
31 Dec 12
Notice of late annual filing
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
1 Nov 12
Entry into a Material Definitive Agreement
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
26 Oct 12
Changes in Registrant's Certifying Accountant
12:00am
8-K/A
NBSE
NeuBase Therapeutics Inc
8 Aug 12
Changes in Registrant's Certifying Accountant
12:00am
10-Q
2012 Q3
NBSE
NeuBase Therapeutics Inc
Quarterly report
7 Aug 12
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
2 Aug 12
Changes in Registrant's Certifying Accountant
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
19 Jul 12
Departure of Directors or Certain Officers
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
3 Jul 12
Ohr Pharmaceutical Announces $2.9 Million Financing
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
29 May 12
Regulation FD Disclosure
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
14 May 12
U.S. FDA Grants Fast Track Designation to Ohr Pharmaceutical’s Squalamine Eye Drops for the Treatment of Wet-AMD
12:00am
10-Q
2012 Q1
NBSE
NeuBase Therapeutics Inc
Quarterly report
11 May 12
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
9 May 12
Regulation FD Disclosure
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
15 Mar 12
Departure of Directors or Certain Officers
12:00am
UPLOAD
NBSE
NeuBase Therapeutics Inc
24 Feb 12
Letter from SEC
12:00am